Metformin News and Research

RSS
Metformin is the active ingredient in a drug used to treat diabetes mellitus (a condition in which the body cannot control the level of sugar in the blood). It is also being studied in the treatment of cancer. It decreases the amount of glucose (a type of sugar) released into the bloodstream from the liver and increases the body’s use of the glucose. Metformin is a type of antidiabetic agent.
Genome-wide molecular tests can guide treatment in recurrent glioblastoma, study shows

Genome-wide molecular tests can guide treatment in recurrent glioblastoma, study shows

Researchers evaluate potential of stem cells, therapeutic agents in neurodegenerative diseases

Researchers evaluate potential of stem cells, therapeutic agents in neurodegenerative diseases

Review finds no increased cancer risk for people taking oral diabetes medication

Review finds no increased cancer risk for people taking oral diabetes medication

Doctors and older patients should work together to dial back diabetes treatment, study suggests

Doctors and older patients should work together to dial back diabetes treatment, study suggests

Abdominal weight found to be key predictor of cancer risk in  postmenopausal women

Abdominal weight found to be key predictor of cancer risk in postmenopausal women

Climbing cost of decades-old drugs threatens to break Medicaid bank

Climbing cost of decades-old drugs threatens to break Medicaid bank

Majority of primary care providers could not recognize all risk factors for prediabetes, survey finds

Majority of primary care providers could not recognize all risk factors for prediabetes, survey finds

Study identifies potential treatment for fetal alcohol spectrum disorder

Study identifies potential treatment for fetal alcohol spectrum disorder

Gelesis reports completion of treatment for last patient in pivotal GLOW study

Gelesis reports completion of treatment for last patient in pivotal GLOW study

SLU scientists receive grant to investigate link between diabetes drug and dementia risk

SLU scientists receive grant to investigate link between diabetes drug and dementia risk

Review highlights effective treatment options for managing patients with T2D and osteoporosis

Review highlights effective treatment options for managing patients with T2D and osteoporosis

Broccoli may help type 2 diabetes patients manage their blood sugar, study finds

Broccoli may help type 2 diabetes patients manage their blood sugar, study finds

Finger-stick blood test may not help diabetes patients who do not use insulin, study shows

Finger-stick blood test may not help diabetes patients who do not use insulin, study shows

Former pharma reps’ new mission: To school docs on high drug costs

Former pharma reps’ new mission: To school docs on high drug costs

Scientists locate crucial off-switch for central cell control

Scientists locate crucial off-switch for central cell control

Study reveals key role of gut microbiota in treatment with classic diabetes medication

Study reveals key role of gut microbiota in treatment with classic diabetes medication

Research paves way for safer and more effective drugs to treat type 2 diabetes

Research paves way for safer and more effective drugs to treat type 2 diabetes

Diabetes medication could potentially help treat symptoms of Fragile X syndrome

Diabetes medication could potentially help treat symptoms of Fragile X syndrome

Infiniti Research expects rapid growth in global wearable patch market

Infiniti Research expects rapid growth in global wearable patch market

Article highlights link between diabetes and depression as likely cause for increased self-harm rates

Article highlights link between diabetes and depression as likely cause for increased self-harm rates

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.